Pulmonx Corp (LUNG) stock
LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/3044% below fair value
$2.69−0.04 (-1.65%)
Close on Nov 18, 2026Market cap $115.53MP/E –Yield –
Pulmonx net income
Net income is the profit left for shareholders after every expense, interest and tax.
Pulmonx's net income for the twelve months ending Jun 30, 2026 was -$48.12M. For fiscal 2025 it was -$54.00M. The highest annual figure on record is -$18.48M in fiscal 2018.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$54.00M | – |
| FY2024 | Dec 31, 2024 | -$56.39M | – |
| FY2023 | Dec 31, 2023 | -$60.84M | – |
| FY2022 | Dec 31, 2022 | -$58.92M | – |
| FY2021 | Dec 31, 2021 | -$48.66M | – |
| FY2020 | Dec 31, 2020 | -$32.23M | – |
| FY2019 | Dec 31, 2019 | -$20.70M | – |
| FY2018 | Dec 31, 2018 | -$18.48M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$10.08M | – |
| Q1 FY2026 | Mar 31, 2026 | -$13.65M | – |
| Q4 FY2025 | Dec 31, 2025 | -$10.43M | – |
| Q3 FY2025 | Sep 30, 2025 | -$13.96M | – |
| Q2 FY2025 | Jun 30, 2025 | -$15.17M | – |
| Q1 FY2025 | Mar 31, 2025 | -$14.45M | – |
| Q4 FY2024 | Dec 31, 2024 | -$13.18M | – |
| Q3 FY2024 | Sep 30, 2024 | -$14.14M | – |
| Q2 FY2024 | Jun 30, 2024 | -$15.33M | – |
| Q1 FY2024 | Mar 31, 2024 | -$13.75M | – |
| Q4 FY2023 | Dec 31, 2023 | -$13.89M | – |
| Q3 FY2023 | Sep 30, 2023 | -$14.90M | – |
| Q2 FY2023 | Jun 30, 2023 | -$16.20M | – |
| Q1 FY2023 | Mar 31, 2023 | -$15.86M | – |
| Q4 FY2022 | Dec 31, 2022 | -$14.28M | – |
| Q3 FY2022 | Sep 30, 2022 | -$14.17M | – |
| Q2 FY2022 | Jun 30, 2022 | -$14.64M | – |
| Q1 FY2022 | Mar 31, 2022 | -$15.83M | – |
| Q4 FY2021 | Dec 31, 2021 | -$13.01M | – |
| Q3 FY2021 | Sep 30, 2021 | -$10.18M | – |
| Q2 FY2021 | Jun 30, 2021 | -$12.96M | – |
| Q1 FY2021 | Mar 31, 2021 | -$12.51M | – |
| Q4 FY2020 | Dec 31, 2020 | -$9.30M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.86M | – |
| Q2 FY2020 | Jun 30, 2020 | -$11.91M | – |
| Q1 FY2020 | Mar 31, 2020 | -$7.16M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.67M | – |
| Q3 FY2019 | Sep 30, 2019 | -$4.34M | – |
| Q2 FY2019 | Jun 30, 2019 | -$5.57M | – |
| Q1 FY2019 | Mar 31, 2019 | -$6.13M | – |
See a number that looks wrong?